Xie, Ji-yan
Wei, Jin-xing
Lv, Li-hong
Han, Qing-fang
Yang, Wei-bang
Li, Guo-lin
Wang, Pan-xia
Wu, Shao-bin
Duan, Jin-xin
Zhuo, Wen-feng
Liu, Pei-qing
Min, Jun
Funding for this research was provided by:
National Natural Science Foundation of China (81672420, 81702406, 81673433)
National Engineering and Technology Research Center for New drug Druggability Evaluation (Seed Program of Guangdong Province, 2017B090903004)
Article History
Received: 22 October 2019
Accepted: 13 February 2020
First Online: 17 March 2020
Ethics approval and consent to participate
: Tissue and serum samples were collected from patients after obtaining informed consent in accordance with a protocol approved by the Ethics Committee of Sun Yat-sen Memorial Hospital (Guangzhou, China). All experimental procedures involving animals were performed according to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication No. 85–23, revised 2011) and in accordance with the institutional ethical guidelines for animal experiments.
: Not applicable.
: The authors declare that they have no competing interests.